FAKTOR-OPTIONSSCHEIN - BRISTOL-MYERS SQUIBB | Market Closed - Boerse Frankfurt Warrants 03:50:59 2024-07-10 pm EDT | ||
| 1.39 EUR | +1.46% |
|
| Current month | -3.47% | ||
| 1 month | -9.74% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Latest news about BRISTOL-MYERS SQUIBB COMPANY
| Date | Price | Change |
|---|---|---|
| 24-07-10 | 1.39 | +1.46% |
| 24-07-09 | 1.37 | +7.03% |
| 24-07-08 | 1.28 | +2.40% |
| 24-07-05 | 1.25 | -4.58% |
| 24-07-04 | 1.31 | +3.97% |
Real-time Boerse Frankfurt Warrants
Last update July 10, 2024 at 03:50 pm EDT
More quotesStatic data
| Product type | Exotic Products |
|---|---|
| Buy / Sell | CALL |
| Underlying | BRISTOL-MYERS SQUIBB COMPANY |
| Issuer | 
Société Générale
|
| WKN | SB01G8 |
| ISIN | DE000SB01G83 |
| Date issued | 2020-06-09 |
| Strike | 61.28 $ |
| Maturity | Unlimited |
| Parity | 1 : 1 |
| Emission price | 8.86 € |
| Emission volume | N/A |
| Settlement | cash |
| Currency | EUR |
Technical Indicators
| Highest since issue | 16.65 € |
|---|---|
| Lowest since issue | 1.23 € |
| Spread | 0.01 € |
| Spread % | 0.71% |
Company Profile
Bristol-Myers Squibb Company est spécialisé dans le développement, la fabrication et la commercialisation de produits pharmaceutiques. Les produits sont destinés au traitement des cancers, des maladies cardio-vasculaires, de l'hépatite, des maladies immunitaires et des désordres psychiatriques.
The United States account for 70.1% of net sales.
Sector
-
Ratings for Bristol-Myers Squibb Company
Trading Rating
Investor Rating
ESG Refinitiv
B
Consensus: Bristol-Myers Squibb Company
Sell
Buy
Mean consensus
HOLD
Number of Analysts
26
Last Close Price
41.12
USD
Average target price
53.1
USD
Spread / Average Target
+29.14%
- Stock Market
- Certificates
- Certificat
